---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-018098"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2025-07-08T23:59:59+00:00"
generated_at: "2026-05-18T09:13:23.823655+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Microbot to present at inaugural SRS Endovascular Robotics session; FDA 510(k) decision expected this quarter

## Summary
- Participates in Society of Robotic Surgery annual meeting July 16-20 in Strasbourg, France.
- CEO Harel Gadot to present overview of endovascular robotics market at panel on July 19.
- Company strengthening sales & marketing infrastructure ahead of anticipated U.S. FDA 510(k) decision this quarter.
- Liberty system remains investigational; not yet approved for sale in the U.S.

## SEC filing metadata
- accession: 0001641172-25-018098
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2025-07-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000164117225018098/0001641172-25-018098-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000164117225018098/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-018098
- JSON: https://secwatch.observer/filing/0001641172-25-018098.json
- Plain text: https://secwatch.observer/filing/0001641172-25-018098.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.